Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2215 EUR | -2.42% | +0.45% | -82.34% |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Mar. 08 | Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 40.16M 43.02M | Sales 2024 * | 43.9M 47.03M | Capitalization | 15.31M 16.4M |
---|---|---|---|---|---|
Net income 2023 | -174M -186M | Net income 2024 * | -55M -58.92M | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 332M | Net Debt 2024 * | 166M 178M | EV / Sales 2024 * | 4.14 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | -2.42% | ||
1 week | +0.45% | ||
Current month | -20.61% | ||
1 month | -7.71% | ||
3 months | -80.15% | ||
6 months | -80.54% | ||
Current year | -82.34% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17-02-22 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 23-05-28 |
Christian Homsy
CHM | Chairman | 65 | 23-05-28 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 21-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.2215 | -2.42% | 17,523 |
24-04-23 | 0.227 | +2.48% | 44,805 |
24-04-22 | 0.2215 | -1.12% | 120,811 |
24-04-19 | 0.224 | -3.86% | 63,556 |
24-04-18 | 0.233 | +5.67% | 36,373 |
Real-time Euronext Bruxelles, April 24, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.34% | 16.36M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+53.11% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
-0.22% | 8.31B |
- Stock Market
- Equities
- MITRA Stock